Keele Research Repository

Article

Ramachandran, S, Hackett, GI and Strange, RC (2020) Testosterone replacement therapy: Pre-treatment sex hormone binding globulin levels and age may identify clinical subgroups. Andrology.

Strange, RC, Ramachandran, S and Hackett, GI (2019) Sex hormone binding globulin: A review of its interactions with testosterone and age, and its impact on mortality in men with type 2 diabetes. Sexual Medicine Reviews.

Strange, RC, Ramachandran, S, Livingston, M and Hackett, GI (2019) Should laboratory assay quality be described in study publications and clinical guidelines? A focus on testosterone assay performance. Edorium Journal of Biochemistry.

Strange, RC, Ramachandran, S, Hackett, GI, Balabani, S and König, CS (2019) Testosterone therapy: An assessment of the clinical consequences of changes in haematocrit and blood flow characteristics. Sexual Medicine Reviews.

Strange, RC, Ramachandran, S, Hackett, GI, Mulay, A and Cole, N (2019) Long-term Testosterone Therapy in Type 2 Diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU International, 123 (3). pp. 219-529.

Ramachandran, S, Strange, RC, Fryer, AA, Saad, F and Hackett, GI (2018) The association of sex hormone binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes. Andrology, 6 (6). pp. 846-853.

Hackett, GI, Cole, N, Mulay, A, Strange, RC and Ramachandran, S (2018) Long-term testosterone therapy in type 2 diabetes is associated with decreasing waist circumference and improving erectile function. World Journal of Men's Health, 38 (1). pp. 68-77.